Use of GRA6-derived synthetic polymorphic peptides in an immunoenzymatic assay to serotype Toxoplasma gondii in human serum samples collected from three continents
about
Diagnosis of toxoplasmosis and typing of Toxoplasma gondiiAnalysis of clonal type-specific antibody reactions in Toxoplasma gondii seropositive humans from Germany by peptide-microarrayImportance of serological cross-reactivity among Toxoplasma gondii, Hammondia spp., Neospora spp., Sarcocystis spp. and Besnoitia besnoiti.Selective and strain-specific NFAT4 activation by the Toxoplasma gondii polymorphic dense granule protein GRA6.Strain hypothesis of Toxoplasma gondii infection on the outcome of human diseases.A systematic review and meta-analysis of Toxoplasma gondii infection among the Mexican population.Serotyping of Toxoplasma gondii in cats (Felis domesticus) reveals predominance of type II infections in GermanySelection of polymorphic peptides from GRA6 and GRA7 sequences of Toxoplasma gondii strains to be used in serotypingGenetic characterization of Toxoplasma gondii isolates from Portugal, Austria and Israel reveals higher genetic variability within the type II lineage.Genotype analysis of T. gondii strains associated with human infection in Egypt.Genotyping of Toxoplasma gondii and Sarcocystis spp. in road-killed wild mammals from the Central Western Region of the State of São Paulo, Brazil.Toxoplasma vaccines: appropriate end points and sample size in future human clinical trials.Severe pulmonary toxoplasmosis after allo-SCT in two patients: from Toxoplasma genotyping to clinical management
P2860
Q26998428-889CE780-529E-4BB5-B08A-B8EA1FE51831Q28730892-09A65D09-4F53-462F-9A1D-AFA79B9387FAQ33801721-E2CBCC65-FF6F-4618-9C48-02574947F131Q34230563-F07080BB-C74B-4E3F-8039-3A489AEA47DDQ35181148-796C67C4-7E67-436D-8885-7F71EAA21050Q36547845-33569377-1523-4C09-848F-D86FC5C9DE8AQ37288395-BB4DE501-6330-4DC9-8BB5-8A64FC54A7A8Q37301881-A1F9F60C-00E9-4A5F-AA07-3CBB767A2B98Q39039554-26897205-1EAE-41E2-9987-ABB60F9B831EQ39527612-D24627BC-6308-47BB-B0A6-3B028025B722Q40464205-C3704DB4-4C23-4792-B56E-30F03C016E89Q47172807-E3DF2916-A3DD-4798-A642-44738BD75504Q58838847-3A3D8DEC-B0B1-454E-AA4F-CEE7EF248CB4
P2860
Use of GRA6-derived synthetic polymorphic peptides in an immunoenzymatic assay to serotype Toxoplasma gondii in human serum samples collected from three continents
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Use of GRA6-derived synthetic ...... ollected from three continents
@en
type
label
Use of GRA6-derived synthetic ...... ollected from three continents
@en
prefLabel
Use of GRA6-derived synthetic ...... ollected from three continents
@en
P2860
P50
P356
P1476
Use of GRA6-derived synthetic ...... ollected from three continents
@en
P2093
José Costa
Marie-Laure Dardé
P2860
P304
P356
10.1128/CVI.00186-08
P577
2008-07-30T00:00:00Z